Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
イブプロフェンの正荷電水溶性プロドラッグ
Document Type and Number:
Japanese Patent JP5144658
Kind Code:
B2
Abstract:
Pro-drugs of ibuprofen comprising a thiopropionate or propionamide moiety, wherein the amino group is tertiary and protonated. This positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. Diethylaminoethyl 2-(p-isobutylphenyl) propionate.AcOH for example diffuses through human skin 250 times faster than ibuprofen itself and 125 times faster than ethyl 2-(p-isobutylphenyl) propionate. In plasma, more than 90% of these pro-drugs can change back to the drug in a few minutes. The prodrugs can be used medicinally in treating any ibuprofen-treatable conditions in humans or animals and be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of ibuprofen, most notably GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrug enables the ibuprofen to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of ibuprofen.

Inventors:
You Chongshi
Shurina
Application Number:
JP2009520065A
Publication Date:
February 13, 2013
Filing Date:
July 18, 2006
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Techfields Biochem Company Limited
You Chongshi
International Classes:
C07C211/63; A61K9/06; A61K9/08; A61K9/107; A61K31/165; A61K31/216; A61P11/06; A61P15/00; A61P17/00; A61P17/10; A61P19/02; A61P25/04; A61P25/06; A61P27/02; A61P27/06; A61P27/14; A61P27/16; A61P29/00; A61P35/00; C07C209/74; C07C231/02; C07C233/36; C07C327/30
Domestic Patent References:
JP64052742A
JP2005504121A
JP2004525112A
JP2009542797A
JP2009544685A
JP2010500989A
Foreign References:
EP0237495A1
Other References:
J. Med. Chem.,2005年,48,4312-4331
Attorney, Agent or Firm:
Sadao Kumakura
Nobuo Ogawa
Atsushi Hakoda
Kenji Asai
Koji Hirayama